Avara to buy ex Crestor API plant from AstraZeneca

By Gareth Macdonald contact

- Last updated on GMT

iStock/Choreograph
iStock/Choreograph

Related tags: Astrazeneca

Avara Pharmaceutical Services will buy the UK manufacturing facility at which AstraZeneca made the API for Crestor and Seroquel.

The deal – financial terms of which were not disclosed – will see US based Avara buy the plant in Avlon, UK and take on 210 employees. The firm has also been contracted to supply AstraZeneca with active pharmaceutical ingredients (API).

The facility was earmarked for closure in 2008 when AstraZeneca said it would outsource production of the ingredients for blockbuster cardiovascular drug Crestor (rosuvastatin) and schizophrenia drug Seroquel (Quetiapine).

In 2014 AstraZeneca reiterated the closure plan and said it would wind up operations by 2017. At the time a spokesman told us “The majority of API manufacturing undertaken at Avlon will be outsourced once the site closes.”​ 

News of the deal comes less than a month after Avara said it is buying the contract manufacturing business of Japanese drug producer Astellas Pharma. The deal, financial terms of which were not disclosed, also saw Avara contracted to make products for Astellas.

Related news

Show more

Related products

show more

LACTIUM®: dairy bioactive to soothe your pet

LACTIUM®: dairy bioactive to soothe your pet

Ingredia | 12-Oct-2021 | Infographic

Lactium® gives you the chance to better meet your pet’s needs for a more harmonious life together. Lactium® acts on the brain and has no side-effects,...

Facilities: Lexington, KY USA

Facilities: Lexington, KY USA

Piramal Pharma Solutions | 23-Aug-2021 | Insight Guide

The Piramal Pharma Solutions facility in Lexington, KY USA is a fully integrated site which offers analytical, formulation development, and manufacturing...

Follow us

Products

View more

Webinars